RNA Interference: Application to Drug Discovery and Challenges to Pharmaceutical Development provides a general overview of this rapidly emerging field, with a strong emphasis on issues and aspects that are important to a drug development team. The first part covers more general background of RNA interference and its application in drug discovery. In the second part, the book addresses siRNA (small interfering RNA), a pharmaceutically potent form, and its use and delivery in therapeutics along with manufacturing and delivery aspects.
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
PAUL H. JOHNSON, PhD, is a cofounder and Chief Scientific Officer at PhaseRx, Inc. He is the author of numerous scientific papers and patents, and was the recipient of the 2007 Jeffrey Wenig Memorial Award for Outstanding Achievement in Drug Delivery.
A general overview of RNA interference for the novice reader
Today, RNA molecules are used extensively in academic labs and the pharmaceutical industry to probe gene function and validate gene and protein targets for drug discovery. This book provides an overview of RNA interference for those unfamiliar with this rapidly emerging field. It covers mechanisms of action, its applications as a target validation and identification tool, toxicity concerns, and development of siRNA molecules as novel therapeutics.
Written by experts in the field, each chapter focuses on an important aspect of RNAi biology or therapeutic discovery and application. While various aspects of current research, important discoveries, technology description, and methodology are covered, the book focuses on identifying issues that must be overcome for the successful development of RNAi technology. With a strong emphasis on issues and aspects that are important to a drug development team, the book:
Presents a general overview of RNA interference biology, along with a strong emphasis on therapeutic applications issues important for drug development
Addresses siRNA (small interfering RNA), a pharmaceutically-potent form, and how it is used in therapeutics, along with toxicity and delivery aspects
Emphasizes industrial applications such as chemical modifications and delivery
Focuses on gene function validation and siRNA as a new class of therapeutics
Includes pharmaceutical topics of discovery and development of delivery agents, toxicity, and viral disease applications
Clear, easy to understand, and focused on key issues for future research and development, RNA Interference is intended for non-specialist scientists, working in both academia and the pharmaceutical industry, who need to know and work within the dynamic area of RNA interference.
A general overview of RNA interference for the novice reader
Today, RNA molecules are used extensively in academic labs and the pharmaceutical industry to probe gene function and validate gene and protein targets for drug discovery. This book provides an overview of RNA interference for those unfamiliar with this rapidly emerging field. It covers mechanisms of action, its applications as a target validation and identification tool, toxicity concerns, and development of siRNA molecules as novel therapeutics.
Written by experts in the field, each chapter focuses on an important aspect of RNAi biology or therapeutic discovery and application. While various aspects of current research, important discoveries, technology description, and methodology are covered, the book focuses on identifying issues that must be overcome for the successful development of RNAi technology. With a strong emphasis on issues and aspects that are important to a drug development team, the book:
Presents a general overview of RNA interference biology, along with a strong emphasis on therapeutic applications issues important for drug development
Addresses siRNA (small interfering RNA), a pharmaceutically-potent form, and how it is used in therapeutics, along with toxicity and delivery aspects
Emphasizes industrial applications such as chemical modifications and delivery
Focuses on gene function validation and siRNA as a new class of therapeutics
Includes pharmaceutical topics of discovery and development of delivery agents, toxicity, and viral disease applications
Clear, easy to understand, and focused on key issues for future research and development, RNA Interference is intended for non-specialist scientists, working in both academia and the pharmaceutical industry, who need to know and work within the dynamic area of RNA interference.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Anbieter: Studibuch, Stuttgart, Deutschland
hardcover. Zustand: Gut. 340 Seiten; 9780471771517.3 Gewicht in Gramm: 1. Artikel-Nr. 1067603
Anzahl: 1 verfügbar
Anbieter: Ria Christie Collections, Uxbridge, Vereinigtes Königreich
Zustand: New. In. Artikel-Nr. ria9780471771517_new
Anzahl: Mehr als 20 verfügbar
Anbieter: moluna, Greven, Deutschland
Zustand: New. PAUL H. JOHNSON, PhD, is a cofounder and Chief Scientific Officer at PhaseRx, Inc. He is the author of numerous scientific papers and patents, and was the recipient of the 2007 Jeffrey Wenig Memorial Award for Outstanding Achievement in Drug Delivery.A . Artikel-Nr. 556562500
Anzahl: Mehr als 20 verfügbar
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
Hardcover. Zustand: Brand New. 1st edition. 310 pages. 9.75x6.50x1.00 inches. In Stock. Artikel-Nr. x-0471771511
Anzahl: 2 verfügbar
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Neuware - RNA Interference: Application to Drug Discovery and Challenges to Pharmaceutical Development provides a general overview of this rapidly emerging field, with a strong emphasis on issues and aspects that are important to a drug development team. The first part covers more general background of RNA interference and its application in drug discovery. In the second part, the book addresses siRNA (small interfering RNA), a pharmaceutically potent form, and its use and delivery in therapeutics along with manufacturing and delivery aspects. Artikel-Nr. 9780471771517
Anzahl: 2 verfügbar
Anbieter: Kennys Bookstore, Olney, MD, USA
Zustand: New. RNA Interference: Application to Drug Discovery and Challenges to Pharmaceutical Development provides a general overview of this rapidly emerging field, with a strong emphasis on issues and aspects that are important to a drug development team. Editor(s): Johnson, Paul H. Num Pages: 328 pages, Illustrations. BIC Classification: PN; PSAK1. Category: (P) Professional & Vocational. Dimension: 243 x 160 x 24. Weight in Grams: 646. . 2011. 1st Edition. Hardcover. . . . . Books ship from the US and Ireland. Artikel-Nr. V9780471771517
Anzahl: Mehr als 20 verfügbar